Cargando…
P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430974/ http://dx.doi.org/10.1097/01.HS9.0000971472.03345.ef |
| _version_ | 1785091088242966528 |
|---|---|
| author | Ozcan, Muhit Song, Yuqin Tae Lee, Seung Mensah, Felix Modi, Dipenkumar Fossa, Alexander Seog Kim, Won Paszkiewicz-Kozik, Ewa Sawalha, Yazeed Gokmen Sevindik, Omur Norasetthada, Lalita Santoro, Armando Pathiraja, Kumudu Chakraborty, Samhita Marinello, Patricia Lavie, David |
| author_facet | Ozcan, Muhit Song, Yuqin Tae Lee, Seung Mensah, Felix Modi, Dipenkumar Fossa, Alexander Seog Kim, Won Paszkiewicz-Kozik, Ewa Sawalha, Yazeed Gokmen Sevindik, Omur Norasetthada, Lalita Santoro, Armando Pathiraja, Kumudu Chakraborty, Samhita Marinello, Patricia Lavie, David |
| author_sort | Ozcan, Muhit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430974 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309742023-08-17 P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) Ozcan, Muhit Song, Yuqin Tae Lee, Seung Mensah, Felix Modi, Dipenkumar Fossa, Alexander Seog Kim, Won Paszkiewicz-Kozik, Ewa Sawalha, Yazeed Gokmen Sevindik, Omur Norasetthada, Lalita Santoro, Armando Pathiraja, Kumudu Chakraborty, Samhita Marinello, Patricia Lavie, David Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430974/ http://dx.doi.org/10.1097/01.HS9.0000971472.03345.ef Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ozcan, Muhit Song, Yuqin Tae Lee, Seung Mensah, Felix Modi, Dipenkumar Fossa, Alexander Seog Kim, Won Paszkiewicz-Kozik, Ewa Sawalha, Yazeed Gokmen Sevindik, Omur Norasetthada, Lalita Santoro, Armando Pathiraja, Kumudu Chakraborty, Samhita Marinello, Patricia Lavie, David P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title | P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title_full | P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title_fullStr | P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title_full_unstemmed | P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title_short | P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) |
| title_sort | p1144: phase 2 waveline-004 study: zilovertamab vedotin (mk-2140) in relapsed/refractory (r/r) diffuse large b-cell lymphoma (dlbcl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430974/ http://dx.doi.org/10.1097/01.HS9.0000971472.03345.ef |
| work_keys_str_mv | AT ozcanmuhit p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT songyuqin p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT taeleeseung p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT mensahfelix p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT modidipenkumar p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT fossaalexander p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT seogkimwon p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT paszkiewiczkozikewa p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT sawalhayazeed p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT gokmensevindikomur p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT norasetthadalalita p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT santoroarmando p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT pathirajakumudu p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT chakrabortysamhita p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT marinellopatricia p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl AT laviedavid p1144phase2waveline004studyzilovertamabvedotinmk2140inrelapsedrefractoryrrdiffuselargebcelllymphomadlbcl |